ライフサイエンスコーパス: brachial artery

1 improves flow-mediated dilation (FMD) of the brachial artery.

2 nd nitroglycerin-induced vasodilation of the brachial artery.

3 maging and cuff pressure measurements in the brachial artery.

4 asound to measure changes in diameter of the brachial artery.

5 lation (NID; endothelium independent) of the brachial artery.

6 ) were assessed by ultrasound imaging of the brachial artery.

7 ans of flow-mediated dilatation (FMD) of the brachial artery.

8 or measuring flow-mediated dilatation of the brachial artery.

9 studies were performed by infusion into the brachial artery.

10 ction and cold pressor responsiveness of the brachial artery.

11 ed by high-resolution ultrasonography of the brachial artery.

12 stischemic flow-mediated vasodilation of the brachial artery.

13 gs and electrolytes were infused through the brachial artery.

14 etected by cuff pressure measurements in the brachial artery.

15 s improved flow-mediated vasodilation of the brachial artery.

16 t and -independent vascular responses of the brachial artery.

17 -1). min(-1), n = 9) or saline (n = 8) via a brachial artery.

18 -induced flow-mediated dilation (FMD) of the brachial artery.

19 ressure was recorded non-invasively from the brachial artery.

20 aneous low-frequency US energy dilates human brachial arteries.

21 neous low-frequency ultrasound (US) in human brachial arteries.

22 in endothelial cells (ECs) obtained from the brachial artery (1.25+/-0.12 versus 0.61+/-0.11 nitrotyr

23 , P=0.546), on flow-mediated dilation of the brachial artery (11.9+/-6.3% versus 11.4+/-7.9%, P=0.742

24 endothelium-dependent dilation (EDD) of the brachial artery; 2) combined serum nitrite/nitrate (NOx)

25 t, we assessed (1) flow-mediated dilation of brachial artery; (2) coronary flow reserve, ejection fra

26 and autologously transfused into the forearm brachial artery 5 and 42 days after blood donation.

27 Flow-mediated dilation (FMD) of the brachial artery, a measure of endothelial function, was

28 nt vasodilation was measured via incremental brachial artery administration of methacholine chloride

29 ent vasodilation was measured by incremental brachial artery administration of methacholine chloride

30 nous occlusion plethysmography) responses to brachial artery administration of prazosin (an alpha(1)-

31 Brachial artery and antecubital vein catheters were plac

32 y) for 45 min with catheters inserted in the brachial artery and both femoral veins.

33 Flow-mediated dilation (FMD) of the brachial artery and E-selectin, von Willebrand factor, a

34 ysfunction in CHF, as assessed by FMD in the brachial artery and exhaled NO production during submaxi

35 ressed by a smaller percentage of FMD of the brachial artery and higher salivary levels of MMP-2/TIMP

36 Blood was sampled simultaneously from the brachial artery and internal jugular and femoral veins w

37 etal blood samples were drawn from the fetal brachial artery and jugular veins at several time points

38 Catheters were placed in the brachial artery and sagittal sinus vein for collection o

39 essed by flow-mediated dilation (FMD) of the brachial artery and TR jet velocity, respectively.

40 al function (flow-mediated dilatation of the brachial artery) and cardiac function were also measured

41 ulation (flow-mediated dilation [FMD] in the brachial artery) and the pulmonary circulation (exhaled

42 Elite power athletes have larger brachial arteries, and greater vasoreactivity (greater v

43 lood pressure, flow-mediated dilation in the brachial artery, and carotid to radial pulse wave veloci

44 ction by flow-mediated dilation (FMD) of the brachial artery, and evaluated central arterial stiffnes

45 Immediate left brachial artery angiography with subsequent thrombectomy

46 ; similar effects were also observed for the brachial artery ( approximately 25% decrease in blood fl

47 ndent (glyceryl trinitrate [GTN]) changes in brachial artery area were measured using cardiovascular

48 ges in flow-mediated dilatation (FMD) of the brachial artery, arterial stiffness, and blood pressure.

49 ll women using flow-mediated dilation of the brachial artery at 23-25 weeks' gestation.

50 hemia induced by a surgical occlusion of the brachial artery (BAO) induces increased paw-guarding beh

51 lamp)) and endothelial function evaluated by brachial artery blood flow (BAF; Doppler ultrasound) and

52 croneurography), arterial blood pressure and brachial artery blood flow (duplex Doppler ultrasound) w

53 am), oxygen saturation (pulse oximetry), and brachial artery blood flow and shear rate (ultrasound) w

54 We assessed brachial artery blood flow during maximal handgrip exerc

55 scle microvascular recruitment and increased brachial artery blood flow seen in lean individuals.

56 nges in blood pressure (Finapres) divided by brachial artery blood flow velocity (Doppler ultrasound)

57 Studies included brachial artery blood pressure (BP), aortic pulse wave v

58 isease, simple measurements such as standard brachial artery blood pressure, brachial pulse pressure,

59 he assessment of endothelial function in the brachial artery by flow-mediated dilatation (FMD).

60 nt (nitroglycerin) vascular responses of the brachial artery by high-resolution ultrasound imaging.

61 s (IMT), flow-mediated vasodilatation of the brachial artery by ultrasound, assessment of endothelial

62 he assessment of endothelial function in the brachial artery by using flow-mediated dilation.

63 sed local stiffness of carotid, femoral, and brachial arteries (by ultrasonography), carotid-femoral

64 Subsequently, AA was infused via brachial artery catheter for 10 min during continued exe

65 n alpha1 -adrenoceptor agonist) infusion via brachial artery catheter in response to two different st

66 aline or drugs were infused sequentially via brachial artery catheter in the exercising forearm.

67 used (2 ml x min(-1)) into the forearm via a brachial artery catheter to locally inhibit synthesis of

68 the first five subjects, arterial pressure (brachial artery catheter) and forearm blood flow (plethy

69 alpha- and beta-adrenoceptor blockade (via a brachial artery catheter) to eliminate sympathoadrenal i

70 ioxidant vitamin therapy improved FMD of the brachial artery compared with baseline (P<0.001) without

71 therapy were not apparent from conventional brachial artery cuff pressure assessments.

72 inly rely on blood pressure (BP) measured at brachial arteries (cuff BP).

73 In contrast, brachial artery DC progressively increased from baseline

74 The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline

75 Before and after each exposure, brachial artery diameter (BAd) was assessed using ultras

76 Brachial artery diameter (BAD) was measured by ultrasoun

77 egressions were fit to the percent change in brachial artery diameter (flow mediated and nitroglyceri

78 nd P = 0.005, respectively) alongside larger brachial artery diameter (P = 0.015) and lower FMD perce

79 several biomarkers were related to baseline brachial artery diameter (PAI-1, CRP, urine albumin-crea

80 Insulin increased brachial artery diameter and flow in the lean but not in

81 ose clamp) and insulin-stimulated changes in brachial artery diameter and forearm skeletal muscle cap

82 There was no difference in baseline brachial artery diameter between the two groups.

83 Changes in brachial artery diameter during reactive hyperemia were

84 fish consumption and a 0.10-mm lower (1 SD) brachial artery diameter in men (P = 0.01) and a 0.27% s

85 ultrasound was used to measure the change in brachial artery diameter in response to reactive hyperem

86 and EID were measured as percent increase in brachial artery diameter in response to reactive hyperem

87 At 5 min of US, the brachial artery diameter increased by 4.1%.

88 FMD and brachial artery diameter may have similar predictive val

89 Brachial artery diameter was also predictive of CV event

90 2 wk increased insulin-stimulated changes in brachial artery diameter when compared with placebo [med

91 Brachial artery diameter, a predictor of cardiovascular

92 olution ultrasound and Doppler, we evaluated brachial artery diameter, blood flow, and forearm vascul

93 onography was used to measure alterations in brachial artery diameter, endothelial-dependent flow-med

94 (p = 0.010) after controlling for changes in brachial artery diameter, reactive hyperemia, low-densit

95 esolution ultrasonography was used to assess brachial artery diameters at rest and following 5 minute

96 It was hypothesized brachial artery diameters of athletes would be larger, h

97 Brachial artery diameters were measured at rest and 1 mi

98 Brachial artery diameters were measured before and after

99 scular parameters, including: 1) carotid and brachial artery diameters, intima-media thickness, compl

100 Endothelial-dependent and -independent brachial artery dilatation were also assessed by cine MR

101 Brachial arteries dilated in response to sildenafil in c

102 ex of endothelial NO release), flow-mediated brachial artery dilation (as an index of vascular NO bio

103 Flow-mediated brachial artery dilation was measured by ultrasound.

104 heart rate, but had no significant effect on brachial artery dilation.

105 re was no significant effect of treatment on brachial artery dilation.

106 ion, vascular ultrasound was used to measure brachial artery distensibility in 294 healthy adolescent

107 Brachial artery distensibility was measured by a noninva

108 sessed by measurement of the diameter of the brachial artery during flow (flow-mediated dilatation),

109 However, the predictive value of brachial artery endothelial dysfunction for future cardi

110 effect of a low-fat spread with added PSs on brachial artery endothelial function as measured by flow

111 idant vitamins C and E improves coronary and brachial artery endothelial function in patients with co

112 Impaired brachial artery endothelial function independently predi

113 Brachial artery endothelial function is impaired in indi

114 etylcholine infusions (n = 18 patients), and brachial artery endothelial function was assessed by flo

115 Brachial artery endothelial function was assessed by vas

116 Brachial artery endothelial function, pulmonary function

117 onance imaging; measurement of flow-mediated brachial artery endothelial vasodilation, carotid intima

118 Cardiovascular profiles, brachial artery endothelial-dependent flow-mediated dila

119 ly examine the long-term predictive value of brachial-artery endothelial dysfunction for future cardi

120 otid endarterectomy, p = 0.02), and impaired brachial-artery endothelial function (p = 0.002).

121 Impaired brachial-artery endothelial function independently predi

122 Brachial-artery endothelial function is impaired in indi

123 We examined brachial-artery endothelial function using ultrasound in

124 velocity; 3) coronary calcification; and 4) brachial artery endothelium-dependent and -independent v

125 Brachial artery endothelium-independent dilatation (subl

126 Higher resting brachial artery flow (OR, 1.23 [95% CI, 1.04-1.46]) and

127 During each trial, brachial artery flow mediated dilation (FMD) was used to

128 nd following 5 minutes of forearm occlusion (Brachial Artery Flow Mediated Dilation = BAFMD) and a co

129 ous and venous plasma carnitine difference x brachial artery flow), and carnitine disappearance (Rd)

130 We also measured brachial artery flow, fasting lipid profile, and anthrop

131 Brachial artery flow-mediated (endothelium-dependent) an

132 Brachial artery flow-mediated dilatation (endothelium de

133 At baseline, brachial artery flow-mediated dilatation (FMD) was 55% l

134 Endothelial function assessed by brachial artery flow-mediated dilatation (FMD) was measu

135 Carotid intima-media thickness (IMT) and brachial artery flow-mediated dilatation (FMD) were meas

136 Brachial artery flow-mediated dilatation (FMD), normaliz

137 systemic vasculature was investigated using brachial artery flow-mediated dilatation and carotid art

138 METHODS AND Brachial artery flow-mediated dilatation and cIMT were m

139 d endothelial function was assessed from the brachial artery flow-mediated dilatation response.

140 Ch (P:=0.0414) were markedly attenuated, and brachial artery flow-mediated dilatation was depressed.

141 Brachial artery flow-mediated dilatation was determined

142 Brachial artery flow-mediated dilatation was measured at

143 ve was to quantify endothelial function (via brachial artery flow-mediated dilatation) at sea level (

144 ve was to quantify endothelial function (via brachial artery flow-mediated dilatation) at sea level (

145 pressure, uterine artery pulsatility index, brachial artery flow-mediated dilatation, and serum conc

146 controlled pilot study, we observed improved brachial artery flow-mediated dilation (7.7 +/- 2.9% to

147 hed non-smoking control subjects we examined brachial artery flow-mediated dilation (FMD) and circula

148 Brachial artery flow-mediated dilation (FMD) and nitrogl

149 ndpoint was the week 24 within-arm change in brachial artery flow-mediated dilation (FMD) in particip

150 Although brachial artery flow-mediated dilation (FMD) predicts re

151 Brachial artery flow-mediated dilation (FMD) was determi

152 lood were collected from a forearm vein, and brachial artery flow-mediated dilation (FMD) was measure

153 was reconstructed by mathematical modeling; brachial artery flow-mediated dilation (FMD) was measure

154 pressure, aortic pulse wave velocity (PWV), brachial artery flow-mediated dilation (FMD), and serum

155 examined a measure of endothelial function, brachial artery flow-mediated dilation (FMD), expressed

156 take and brachial artery measures, including brachial artery flow-mediated dilation (FMD), has not be

157 Brachial artery flow-mediated dilation (FMD), urinary 8-

158 eactivity as indexed by direct assessment of brachial artery flow-mediated dilation (FMD).

159 ammatory markers and vascular function using brachial artery flow-mediated dilation (FMD).

160 Brachial artery flow-mediated dilation (FMD, endothelium

161 Coprimary end points included change in brachial artery flow-mediated dilation (FMDBA) and aorti

162 .5% women; mean age, 62 years) with measured brachial artery flow-mediated dilation (n=1446) or hyper

163 .03), noncarotid surgery (P=0.05), and lower brachial artery flow-mediated dilation (P=0.007).

164 ly 50% (to 70 +/- 30 mmol/day), and conduit (brachial artery flow-mediated dilation [FMD(BA)]) and re

165 Endothelial function (brachial artery flow-mediated dilation [FMD]) was measur

166 mary end point was change in maximal percent brachial artery flow-mediated dilation after exposure.

167 A strong inverse relation between brachial artery flow-mediated dilation and increasing qu

168 s measured by enzyme-linked immunoassay, and brachial artery flow-mediated dilation and nitroglycerin

169 ignificantly increased endothelium-dependent brachial artery flow-mediated dilation at 16 weeks, wher

170 outcome was change in endothelium-dependent brachial artery flow-mediated dilation at 16 weeks.

171 Salsalate increased brachial artery flow-mediated dilation by 74% (from 4.0+

172 er high-density lipoprotein cholesterol, and brachial artery flow-mediated dilation compared with lea

173 Infusion of vitamin C increased brachial artery flow-mediated dilation during placebo (P

174 with high-resolution ultrasound to determine brachial artery flow-mediated dilation in 50 pediatric h

175 Ultrasound assessment of brachial artery flow-mediated dilation is emerging as a

176 Bruce protocol), applanation tonometry, and brachial artery flow-mediated dilation testing.

177 nded particles, the absolute maximal percent brachial artery flow-mediated dilation was reduced by 0.

178 ll testing, and endothelial assessment using brachial artery flow-mediated dilation were obtained at

179 on raises the possibility that assessment of brachial artery flow-mediated dilation will be useful in

180 The change in brachial artery flow-mediated dilation with salsalate wa

181 ced endothelial dysfunction (as evaluated by brachial artery flow-mediated dilation) after 8 hours.

182 EDD (brachial artery flow-mediated dilation) was approximatel

183 Brachial artery flow-mediated dilation, 24-hour urinary

184 that sleep apnea is associated with impaired brachial artery flow-mediated dilation, a surrogate of e

185 Endothelial function was assessed as brachial artery flow-mediated dilation, and microvascula

186 performance, treadmill walking performance, brachial artery flow-mediated dilation, and quality of l

187 Brachial artery flow-mediated dilation, digital pulse am

188 endothelial function in humans, we measured brachial artery flow-mediated dilation, reactive hyperem

189 For brachial artery flow-mediated dilation, those in the tre

190 Secondary outcomes were brachial artery flow-mediated dilation, treadmill walkin

191 We measured vascular endothelial function by brachial artery flow-mediated dilation.

192 Vascular reactivity was measured by brachial artery flow-mediated dilation.

193 Brachial artery flow-mediated EDV was reduced in FH+ (7.

194 Brachial artery flow-mediated endothelium-dependent vaso

195 Brachial artery flow-mediated vasodilation (FMD) (1.3 vs

196 re and after 6 months, endothelium-dependent brachial artery flow-mediated vasodilation (FMD) and end

197 In 10 of 20 subjects, brachial artery flow-mediated vasodilation (FMD) was mea

198 measured serum lipoproteins and glucose and brachial artery flow-mediated vasodilation (FMD), an ind

199 Primary endpoints were changes in brachial artery flow-mediated vasodilation (FMD), caroti

200 The primary outcome was the change in brachial artery flow-mediated vasodilation (FMD).

201 Oral glucose tolerance and brachial artery flow-mediated, endothelium-dependent vas

202 scular ultrasonography was used to determine brachial artery, flow-mediated, endothelium-dependent, a

203 However, brachial artery FMD (ET: 3.8 +/- 3.0% vs. CT: 4.3 +/- 3.

204 Peak Vo2, brachial artery FMD in response to cuff ischemia, caroti

205 ntervention induced significant decreases in brachial artery FMD of all groups (P < 0.05).

206 METHODS AND Brachial artery FMD was measured in a nested case-cohort

207 tudies assessing carotid IMT and 7 assessing brachial artery FMD%.

208 Brachial artery FMD, carotid-femoral PWV, central AIx, a

209 ughout each exercise bout and in response to brachial artery FMD, measured prior to, immediately afte

210 ive assessment of endothelial function using brachial-artery FMD may serve as a surrogate end point f

211 ved insulin (0.05 mU. kg(-1). min(-1)) via a brachial artery for 4 h under euglycemic conditions.

212 al impairs flow-mediated vasodilation of the brachial artery for at least 4 h; however, co-ingestion

213 ssessed vascular resistance responses in the brachial artery from changes in blood pressure (Finapres

214 sured as flow-mediated dilation (FMD) of the brachial artery, has not been systematically assessed be

215 easured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period comp

216 d by using high-resolution ultrasound in the brachial artery in 64 coarctation patients (44 males and

217 itamins on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemi

218 essed by flow-mediated dilation (FMD) in the brachial artery in response to reactive hyperemia.

219 itroglycerin-mediated dilation or CPT of the brachial artery in the 2 populations.

220 s evaluated by flow-mediated dilation of the brachial artery in vivo and by vasomotor studies in saph

221 Flow-mediated dilatation of the brachial artery increased in the intervention group as c

222 asure forearm blood flow responses to graded brachial artery infusions of the beta-agonist isoprotere

223 the vascular conductance (FVC) responses to brachial artery infusions of two doses of tyramine (evok

224 the vascular conductance (FVC) responses to brachial artery infusions of tyramine (which evokes endo

225 (compared with <10%) significantly improved brachial artery macrovascular flow-mediated vasodilation

226 S AND RESULTS: Flow-mediated dilation of the brachial artery, matrix metalloproteinase-2 and matrix m

227 a similar directionality of association with brachial artery measures observed for nonfried fish cons

228 investigated cross-sectional associations of brachial artery measures with fish intake (ascertained w

229 The relation between dietary fish intake and brachial artery measures, including brachial artery flow

230 cant associations between fish intake or any brachial artery measures.

231 -6 was higher in the iliac arteries than the brachial arteries (median difference 26.5 pg/mL, this di

232 was measured by ultrasound before and after brachial artery occlusion [i.e., flow-mediated dilation

233 en consumption in the thenar eminence during brachial artery occlusion in sickle cell patients and he

234 hyl-L-arginine (L-NMMA) was infused into the brachial arteries of 9 healthy subjects for 5 minutes to

235 Brachial arteries of athletes were larger (Athletes 5.39

236 nsiveness to adenosine (ADO) infusion in the brachial arteries of human subjects.

237 is by examining pulse wave velocity (PWV) in brachial arteries of twin survivors of TTTS treated with

238 graphic examination of flow phantoms and the brachial artery of a healthy volunteer undergoing reacti

239 The brachial artery of the nondominant arm was catheterized,

240 all levels of the aorta and the carotid and brachial artery (p > 0.05 for all).

241 lower in endothelial cells obtained from the brachial artery (P < 0.05), whereas EID did not differ.

242 trogen infusion was adjusted to reduce fetal brachial artery pO(2) by 25%.

243 essed by flow-mediated dilation (FMD) of the brachial artery preexposure, immediately postexposure, a

244 nd arterial stiffening was assessed from the brachial artery pulse pressure.

245 ssed systemic (flow-mediated dilation of the brachial artery, pulse-wave velocity, and carotid intima

246 Brachial artery reactivity (BAR) was calculated as perce

247 thickness (a measure of arterial stiffness), brachial artery reactivity (both flow-mediated dilatatio

248 Flow-mediated brachial artery reactivity test (BART) both before and 3

249 Brachial artery reactivity, using postischemic flow-medi

250 ociated with carotid intima-media thickness, brachial artery reactivity-glycerol trinitrate, serum ur

251 Endothelial function was evaluated using brachial artery reactivity.

252 Measurement of flow-mediated brachial-artery reactivity also revealed a significant r

253 greater retrograde shear likely modulate the brachial artery response, but the reduced total shear al

254 we conducted a novel assessment of vascular brachial artery responses both to ambient pollution and

255 ular ultrasound, we compared carotid IMT and brachial artery responses to reactive hyperemia (endothe

256 of 36 and 0.36 micromol/min into the forearm brachial artery resulted in supra- and near-physiologic

257 Central haemodynamics, brachial artery shear rate (SR) and blood flow profiles

258 on between nonfried fish intake and baseline brachial artery size varies by sex, with suggestive evid

259 and 6 (4%) had incident subclavian/axillary/brachial artery stenosis.

260 e impaired flow-mediated vasodilation of the brachial artery that does not improve after one year of

261 Two pseudoaneurysms arose from the brachial artery; the remainder were in the groin.

262 s of the dorsal pedal, posterior tibial, and brachial arteries to obtain the ankle-brachial index (AB

263 gh-frequency ultrasonographic imaging of the brachial artery to assess endothelium-dependent flow-med

264 ned from the right internal jugular vein and brachial artery to determine concentration differences f

265 ns of high-resolution ultrasonography of the brachial artery to evaluate vasomotor function, with gui

266 e low-Na+ diet, a catheter was placed in the brachial artery to measure forearm blood flow (FBF, plet

267 um-independent vasodilation were assessed by brachial artery ultrasonography.

268 endothelium-dependent vasomotion (EDV) with brachial artery ultrasound (BAUS) imaging predicts the p

269 FMD and BAD were measured by brachial artery ultrasound at the initial examination of

270 Brachial artery ultrasound during reactive hyperemia is

271 Measures included a brachial artery ultrasound to assess flow-mediated dilat

272 Using brachial artery ultrasound, endothelium-dependent, flow-

273 n between endothelial function determined by brachial-artery ultrasound and long-term cardiovascular

274 orphism that lowers kallikrein activity, the brachial artery undergoes eutrophic inward remodeling in

275 and baseline arterial diameter (BAD) of the brachial artery using ultrasound in a large multicity co

276 After 30 minutes of rest, brachial artery vascular function was assessed by ultras

277 In recent studies of brachial artery vasoactivity, a single high-fat meal red

278 osure to CAP plus ozone caused a significant brachial artery vasoconstriction compared with filtered

279 d and underwent measurement of flow-mediated brachial artery vasodilation (FMV), a measure of vascula

280 We preoperatively examined brachial artery vasodilation using ultrasound in 187 pat

281 Similarly, flow-mediated brachial artery vasodilation was impaired during hyperho

282 markers measured at a routine examination to brachial artery vasodilator function (flow-mediated dila

283 biomarkers (representing these pathways) to brachial artery vasodilator function.

284 Blood flow through the femoral and brachial arteries was recorded during whole-body tilt us

285 Flow-mediated dilation of the brachial artery was 25% smaller in ART than in control c

286 Following recovery, the brachial artery was cannulated and flushed with 10 000 U

287 Vasomotor function of the brachial artery was examined at baseline and after each

288 -dependent flow-mediated vasodilation of the brachial artery was increased by 67%, 44%, and 75% in th

289 ent flow-mediated dilatation (ED-FMD) of the brachial artery was measured by high-resolution ultrasou

290 Flow-mediated vasodilation (FMD) of the brachial artery was measured by high-resolution ultrasou

291 Flow-mediated vasodilation of the brachial artery was measured by high-resolution ultrasou

292 Flow-mediated EDV of the brachial artery was measured in 23 male patients (8 nons

293 Flow-mediated dilation of the brachial artery was measured, and CAD patients underwent

294 aorta, and the common carotid artery and the brachial artery were assessed for diastolic and systolic

295 ate, and flow-mediated dilation (FMD) of the brachial artery were evaluated in 123 study participants

296 ependent flow-mediated dilation (FMD) of the brachial artery were examined in 15 children with famili

297 and nitroglycerin-mediated reactivity of the brachial artery were measured in eight nonsmokers, seven

298 ium- dependent flow-mediated dilation of the brachial artery, whereas consumption of water had no eff

299 or adenosine (0.125 and 0.5 mg/min) into the brachial artery while monitoring forearm blood flow (FBF

300 ated endothelium-dependent relaxation of the brachial artery with doses of quercetin ranging from 50